Mark Strobeck, Ph.D.
Board Member
Windtree Therapeutics Inc /De/ (WINT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark Strobeck, Ph.D.
Mark Strobeck, Ph.D. is recorded as Board Member at Windtree Therapeutics Inc /De/ (WINT). Windtree Therapeutics Inc /De/ reported in an 8-K filed August 16, 2023 that Mark Strobeck, Ph.D. was appointed Director, effective August 15, 2023. Windtree Therapeutics Inc /De/ reported in an 8-K filed June 27, 2023 that Mark Strobeck, Ph.D. was appointed member of the Board, effective June 22, 2023.
“Mark Strobeck, Ph.D. 729,893 32,862 1,480,055”
“On June 22, 2023, the board of directors (the "Board") of Windtree Therapeutics, Inc. (the "Company") appointed Mark Strobeck, Ph.D., as a member of the Board, effective as of June 22, 2023, to serve until the Company's 2023 annual meeting of stockholders or until his successor is duly elected and qualified, or until his earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Windtree Therapeutics Inc /De/
Other people whose current roles at this company are on record from its filings.
- Jed Latkin CEO, Board Member
- Craig E. Fraser Chairman, Board Member
- Former Senior VP CFO
- Jamie McAndrew CFO, Chief Accounting Officer
- John Tattory CFO
- Senior VP CFO
- Diane Carman General Counsel
- Andrew Kucharchuk Board Member
- Daniel Geffken Board Member
- Dr. Evan Loh Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.